Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Synthesis of 2-Azaadamantan-6-one: A Missing Isomer.

Wu J, Leas DA, Dong Y, Wang X, Ezell EL, Stack DE, Vennerstrom JL.

ACS Omega. 2018 Sep 30;3(9):11362-11367. doi: 10.1021/acsomega.8b01819. Epub 2018 Sep 18.

2.

Structural Identification and Kinetic Analysis of the in Vitro Products Formed by Reaction of Bisphenol A-3,4-quinone with N-Acetylcysteine and Glutathione.

Stack DE, Conrad JA, Mahmud B.

Chem Res Toxicol. 2018 Feb 19;31(2):81-87. doi: 10.1021/acs.chemrestox.7b00239. Epub 2018 Jan 16.

3.

One-Pot, Metal-Free Conversion of Anilines to Aryl Bromides and Iodides.

Leas DA, Dong Y, Vennerstrom JL, Stack DE.

Org Lett. 2017 May 19;19(10):2518-2521. doi: 10.1021/acs.orglett.7b00771. Epub 2017 May 8.

4.

NMR analysis of t-butyl-catalyzed deuterium exchange at unactivated arene localities.

Stack DE, Eastman R.

J Labelled Comp Radiopharm. 2016 Oct;59(12):500-505. doi: 10.1002/jlcr.3440. Epub 2016 Sep 19.

5.

Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate.

Stack DE.

Metabolites. 2015 Sep 10;5(3):475-88. doi: 10.3390/metabo5030475.

6.

Regioselective deuterium labeling of estrone and catechol estrogen metabolites.

Stack DE, Ritonya J, Jakopovic S, Maloley-Lewis B.

Steroids. 2014 Dec;92:32-8. doi: 10.1016/j.steroids.2014.08.018. Epub 2014 Aug 28.

PMID:
25174785
7.

Latent class analysis of the Yale-Brown Obsessive-Compulsive Scale symptoms in obsessive-compulsive disorder.

Delucchi KL, Katerberg H, Stewart SE, Denys DA, Lochner C, Stack DE, den Boer JA, van Balkom AJ, Jenike MA, Stein DJ, Cath DC, Mathews CA.

Compr Psychiatry. 2011 May-Jun;52(3):334-41. doi: 10.1016/j.comppsych.2010.06.007. Epub 2010 Aug 5.

8.

Symptom dimensions in OCD: item-level factor analysis and heritability estimates.

Katerberg H, Delucchi KL, Stewart SE, Lochner C, Denys DA, Stack DE, Andresen JM, Grant JE, Kim SW, Williams KA, den Boer JA, van Balkom AJ, Smit JH, van Oppen P, Polman A, Jenike MA, Stein DJ, Mathews CA, Cath DC.

Behav Genet. 2010 Jul;40(4):505-17. doi: 10.1007/s10519-010-9339-z. Epub 2010 Apr 2.

9.

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

Stewart SE, Jenike EA, Hezel DM, Stack DE, Dodman NH, Shuster L, Jenike MA.

J Clin Psychopharmacol. 2010 Feb;30(1):34-9. doi: 10.1097/JCP.0b013e3181c856de.

PMID:
20075645
10.

Long-term outcome following Intensive Residential Treatment of Obsessive-Compulsive Disorder.

Stewart SE, Stack DE, Tsilker S, Alosso J, Stephansky M, Hezel DM, Jenike EA, Haddad SA, Kant J, Jenike MA.

J Psychiatr Res. 2009 Sep;43(13):1118-23. doi: 10.1016/j.jpsychires.2009.03.012. Epub 2009 May 5.

PMID:
19419736
11.

Mechanistic insights into the Michael addition of deoxyguanosine to catechol estrogen-3,4-quinones.

Stack DE, Li G, Hill A, Hoffman N.

Chem Res Toxicol. 2008 Jul;21(7):1415-25. doi: 10.1021/tx800071u. Epub 2008 Jun 12.

PMID:
18547067
12.

Severe obsessive-compulsive disorder with and without body dysmorphic disorder: clinical correlates and implications.

Stewart SE, Stack DE, Wilhelm S.

Ann Clin Psychiatry. 2008 Jan-Mar;20(1):33-8. doi: 10.1080/10401230701844463.

PMID:
18297584
13.

Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.

Stewart SE, Yen CH, Stack DE, Jenike MA.

J Psychiatr Res. 2006 Sep;40(6):511-9. Epub 2005 Oct 17.

PMID:
16229857
14.

Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive-compulsive disorder.

Stewart SE, Stack DE, Farrell C, Pauls DL, Jenike MA.

J Psychiatr Res. 2005 Nov;39(6):603-9. Epub 2005 Mar 4.

PMID:
16157162
15.

Synthesis of a new fluorescent probe specific for catechols.

Stack DE, Hill AL, Diffendaffer CB, Burns NM.

Org Lett. 2002 Dec 12;4(25):4487-90.

PMID:
12465919
16.

Spectral characterization of fluorescently labeled catechol estrogen 3,4-quinone-derived N7 guanine adducts and their identification in rat mammary gland tissue.

Jankowiak R, Zamzow D, Stack DE, Todorovic R, Cavalieri EL, Small GJ.

Chem Res Toxicol. 1998 Nov;11(11):1339-45.

PMID:
9815195
17.

Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione.

Cao K, Stack DE, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL.

Chem Res Toxicol. 1998 Aug;11(8):909-16.

PMID:
9705753
18.

Metabolic activation and formation of DNA adducts of hexestrol, a synthetic nonsteroidal carcinogenic estrogen.

Jan ST, Devanesan PD, Stack DE, Ramanathan R, Byun J, Gross ML, Rogan EG, Cavalieri EL.

Chem Res Toxicol. 1998 May;11(5):412-9.

PMID:
9585471
19.

Catecholestrogens as procarcinogens: depurinating adducts and tumor initiation.

Stack DE, Cavalieri EL, Rogan EG.

Adv Pharmacol. 1998;42:833-6. No abstract available.

PMID:
9328026
20.

Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.

Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, Rogan EG.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10937-42.

21.

Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides.

Stack DE, Byun J, Gross ML, Rogan EG, Cavalieri EL.

Chem Res Toxicol. 1996 Jul-Aug;9(5):851-9.

PMID:
8828920
22.

Radical cations of benzo[a]pyrene and 6-substituted derivatives: reaction with nucleophiles and DNA.

Stack DE, Cremonesi P, Hanson A, Rogan EG, Cavalieri EL.

Xenobiotica. 1995 Jul;25(7):755-60.

PMID:
7483671

Supplemental Content

Loading ...
Support Center